Thomas G. Auchincloss, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 1,500 shares at $8.52 ($13K) on 2020-03-12, disclosed to the SEC on 2020-03-13.
Open-market purchase of $13k CNCE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| CNCE | BUY | 2018-11-19 | $12K | — | Filing → |
| CNCE | BUY | 2018-11-15 | $12K | — | Filing → |
| CNCE | BUY | 2016-05-16 | $20K | — | Filing → |